SCHEMBL4335151

SCHEMBL4335151

CCOC(=O)C(Cc1ccc(OC)c(CCO)c1)OC(C)C

nearest known ligand 0.42

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 3/20 0.42
PKM P14618 1/20 0.42
PPARA Q07869 7/20 0.41
PPARD Q03181 6/20 0.41
ALDH1A1 P00352 1/20 0.40
TSHR P16473 1/20 0.40
LDHA P00338 1/20 0.39
LMNA P02545 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
PPARG P37231 2/20 0.39
ALOX12 P18054 1/20 0.37
CYP4F2 P78329 1/20 0.37
CYP4A11 Q02928 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4337847 0.91 CYP2D6 (0.45) ALOX15PPARAPPARDALDH1A1TSHR
SCHEMBL4329462 0.91 ALOX15 (0.44) ALOX15PKMPPARAPPARDALDH1A1
SCHEMBL6495805 0.90 PKM (0.44) ALOX15PKMPPARAPPARDALDH1A1
SCHEMBL6506184 0.88 ALOX15 (0.46) ALOX15PKMPPARAPPARDALDH1A1
SCHEMBL4329833 0.87 ALOX15 (0.46) ALOX15PKMPPARAPPARDALDH1A1
SCHEMBL4333251 0.83 ALOX15 (0.57) ALOX15TSHRLDHALMNAALOX12
SCHEMBL6504014 0.82 PPARA (0.47) PPARAPPARDLMNAPPARG
SCHEMBL4329066 0.82 GAA (0.47) ALOX15PKMALDH1A1LDHALMNA
SCHEMBL4333135 0.81 CYP4F2 (0.53) PPARASMN1; SMN2PPARGCYP4F2CYP4A11
SCHEMBL4336878 0.81 CYP2D6 (0.46) ALOX15PKMPPARAPPARDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100522944-C Carboxylic acid derivatives and salts thereof EISAI CO LTD (JP) 2009-08-05 CN disclosed
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
CN-1503774-A Carboxylic acid derivatives and salts thereof ������������ʽ���� 2004-06-09 CN disclosed
US-20040102634-A1 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-05-27 US disclosed
EP-1380562-A1 CARBOXYLIC ACID DERIVATIVE AND SALT THEREOF Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040102634-A1 Carboxylic acid derivative and salt thereof GPR119, IRS1, SLC5A1 ALOX15 1009/4885PKM 4339/4885PPARA 339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.